Skip to main content
SpringerLink
Log in

Clinical and bacteriological features of relapsing shunt-associated meningitis due toAcinetobacter baumannii

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

A case is reported of a patient who developedAcinetobacter baumannii meningitis ten days after a ventriculoperitoneal shunt had been placed for control of elevated intracranial pressure. Intravenous antimicrobial therapy was instituted with imipenem and tobramycin after shunt removal and insertion of a ventriculostomy tube. Following the placement of a ventriculoatrial shunt, clinical and microbiological relapse occurred that was eventually cured after complete removal of the ventricular drainage system and a second course of systemic antibiotics. Relapse was confirmed by modern molecular typing techniques including plasmid DNA fingerprinting and analysis of total genomic DNA by pulsed-field gel electrophoresis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bisno AL: Infections of central nervous system shunts. In: Bisno AL, Waldvogel VA (ed): Infections associated with indwelling medical devices. American Society for Microbiology, Washington, DC, 1989, p. 93–109.

    Google Scholar 

  2. Mayhall CG, Archer NH, Lamb VA, Spadora AC, Baggett JW, Ward JD, Narayan RK: Ventriculostomy-related infections. A prospective epidemiologic study. New England Journal of Medicine 1984, 310: 553–559.

    PubMed  Google Scholar 

  3. Yogev R: Cerebrospinal fluid shunt infections: a personal view. Pediatric Infectious Diseases 1985, 4: 113–118.

    Google Scholar 

  4. Cowan ST: Unusual infections following cerebral operations. With a description ofDiplococcus mucosus (von Lingelsheim). Lancet 1938, ii: 1052–1054.

    Google Scholar 

  5. Siegman-Igra Y, Bar-Yosef S, Gorea A, Avram J: NosocomialAcinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. Clinical Infectious Diseases 1993, 17: 843–849.

    PubMed  Google Scholar 

  6. Beck-Sague CM, Jarvis WR, Brook JH, Culver DH, Potts A, Gay E, Shotts BW, Hill B, Anderson RL, Weinstein MP: Epidemic bacteremia due toAcinetobacter baumannii in five intensive care units. American Journal of Epidemiology 1990, 132: 723–733.

    PubMed  Google Scholar 

  7. Seifert H, Baginski R, Schulze A, Pulverer G: Antimicrobial susceptibility ofAcinetobacter species. Antimicrobial Agents and Chemotherapy 1993, 37: 750–753.

    PubMed  Google Scholar 

  8. Weaver RE, Actis LA: Identification ofAcinetobacter species. Journal of Clinical Microbiology 1994, 32: 1832.

    Google Scholar 

  9. Bouvet PJ, Grimont PA: Identification and biotyping of clinical isolates ofAcinetobacter. Annales de l'institut Pasteur Microbiologie 1987, 138: 569–578.

    Google Scholar 

  10. Hartstein AI, Morthland VH, Rourke JW, Freeman J, Garber S, Sykes R, Rashad AL: Plasmid DNA fingerprinting ofAcinetobacter calcoaceticus subspeciesanitratus from intubated and mechanically ventilated patients. Infection Control and Hospital Epidemiology 1990, 11: 531–538.

    PubMed  Google Scholar 

  11. Seifert H, Schulze A, Baginski R, Pulverer G: Comparison of four different methods in the epidemiological typing ofAcinetobacter baumanii. Journal of Clinical Microbiology 1994, 32: 1816–1819.

    PubMed  Google Scholar 

  12. Al-Khoja MS, Darrell JH: The skin as the source ofAcinetobacter andMoraxella species occurring in blood cultures. Journal of Clinical Pathology 1979, 32: 497–499.

    PubMed  Google Scholar 

  13. Kline MW: Review of recurrent bacterial meningitis. Pediatric Infectious Disease Journal 1989, 8: 630–634.

    PubMed  Google Scholar 

  14. Wen DY, Bottini AG, Hall WA, Haines SJ: Infections in neurologic surgery. The intraventricular use of antibiotics. Neurosurgery Clinics of North America 1992, 3: 343–354.

    PubMed  Google Scholar 

  15. Rodriguez K, Dickinson GM, Greenman RL: Successful treatment of gram-negative bacillary meningitis with imipenem/cilastin. Southern Medical Journal 1985, 78: 731–732.

    PubMed  Google Scholar 

  16. Sánchez JF, Sanz-Hospital J, Guerrero A, Martinez-Beltrán J, Quereda C: Curación con imipenem-cilastino de una meningitis porAcinetobacter calcoaceticus. Enfermedades Infecciosas y Microbiologia Clinica 1991, 9: 512–513.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Medical Microbiology and Hygiene, University of Cologne, Goldenfelsstr. 19-21, 50935, Cologne, Germany

    H. Seifert & G. Pulverer

  2. Department of Neurosurgery, Klinikum Merheim, Cologne, Germany

    W. Richter

Authors
  1. H. Seifert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Richter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Pulverer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seifert, H., Richter, W. & Pulverer, G. Clinical and bacteriological features of relapsing shunt-associated meningitis due toAcinetobacter baumannii . Eur. J. Clin. Microbiol. Infect. Dis. 14, 130–134 (1995). https://doi.org/10.1007/BF02111872

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02111872

Keywords

Search

Navigation